Navigation Links
Tranziger Announces Formation of Global Advisory & Development Team
Date:10/7/2009

LONDON and WASHINGTON, Oct. 7 /PRNewswire/ -- Tranziger Limited announced today the formation of its global advisory and business team to advise and assess companies in the life sciences and healthcare sectors to execute strategic transactions and realise and optimise value from their portfolios in these turbulent times. Tranziger Limited is headquartered in London, England, UK and has offices in Washington, DC and Edinburgh.

The Tranziger team will be attending the upcoming BioPartnering Europe conference from October 12-14 at the Queen Elizabeth Conference Centre in London.

Established in early 2009 by a group of senior, highly experienced international corporate business transactional professionals, Tranziger aims to help the managers and owners of small and mid-tier companies in the Biotechnology, Pharmaceutical, Diagnostics and Medical Technology sectors realise value in the currently challenging global economic environment. The group offers strategic transaction advisory and execution services including Mergers and Acquisitions, Corporate and Commercial Development, Corporate Partnering, technical due diligence, and strategic R&D consultancy. Tranziger also has a proprietary service for venture formation, development and commercialisation utilised by larger corporations, universities, government agencies and investment organizations.

Tranziger distinguishes itself from other groups by the fact that its team members originate from the same peer group as many of their prospective clients and deal partners, combining scientific acumen with seasoned experience at the transactional coalface. The group's geographical reach extends to Europe, North America and Asia Pacific, offering scope for a wider base of creative solutions and deal potential.

Dr. V. Paul Gerskowitch, Executive Chairman of Tranziger, said, "The global downturn has caused an intense reevaluation of business models and priorities. Very many newer spinout and mid-tier companies will struggle to survive, doomed by an inability to raise sufficient capital, partner or grow organically. At the same time, larger companies are increasingly staking claims earlier in all phases of technology development."

Neil J. Campbell, Managing Director, North America, said, "As investors focus ever more on those companies with quality data and revenue potential, the life science and healthcare sectors will likely selectively consolidate around those with top quality offerings. Increasingly, there will be a shift away from financial engineers to business builders. This will be brought about by the rise of so-called third age entrepreneurs and the need to derive more value from technology portfolios, thus spreading the risk. Proactive portfolio management and product/technology life cycle management, achieved via Tranziger's Portfolio Partnering model, will become an ever more urgent and value-driving activity for companies."

About Tranziger Limited

Tranziger was established in 2009 by a group of senior, highly experienced international corporate business transactional professionals. Tranziger aims to help the managers and owners of small and mid-sized companies in the Biotechnology, Pharmaceutical, Diagnostics and Medical Technology sectors realise value in the currently challenging global economic environment. The group offers strategic transaction advisory and execution services including Mergers and Acquisitions, Corporate and Commercial Development, Corporate Partnering, technical due diligence, and strategic R&D consultancy. Tranziger also has a proprietary service for venture formation, development and commercialization utilised by larger corporations, universities, government agencies and investment organizations. Further information about Tranziger can be found at www.tranziger.com.

    Contact:
    Tranziger, Limited
    +44 20 8663 3472
    Dr. Paul Gerskowitch, Executive Chairman
    gerskowitch@tranziger.com
    or
    Neil Campbell, Managing Director North American Operations
    +1 301 792 4345
    campbell@tranziger.com

    Tiberend Strategic Advisors, Inc.
    212-827-0020

    Andrew Mielach
    amielach@tiberendstrategicadvisors.com
    or
    Farrell Denby
    fdenby@tiberendstrategicadvisors.com

SOURCE Tranziger Limited


'/>"/>
SOURCE Tranziger Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Telesoft Announces Advanced Dispute Management Capabilities with Version 9.5
2. Cardiovascular Systems Announces Plans for Second Manufacturing Facility - New Facility Expands CSI's Capacity to Produce Peripheral Arterial Disease Systems
3. Health Department Announces First Doses of H1N1 Vaccine Arrive in Pennsylvania
4. Integrated Benefits Institute Announces Availability of 2008 IBI Benchmarking Industry Reports
5. NIH announces expansion of Rare Diseases Clinical Research Network
6. bioTheranostics Announces Commercial Agreement With Lab21 to Market THEROS CancerTYPE ID(R) Molecular Cancer Classifier in United Kingdom, Ireland and Middle East Countries
7. One Source Industries Announces Promotion
8. The Symphony Guild Announces Artist Lineup for 2009 Event
9. Hanger Orthopedic Group, Inc. Announces Third Quarter 2009 Earnings Release Conference Call
10. China-Biotics, Inc. Announces Closing of Public Offering of Common Stock
11. Trapeze Networks Announces Trapeze Medical, Bringing Medical-Grade Mobility to Healthcare Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
Breaking Medicine Technology: